Fluoxetine attenuates UPR-activation, neuroinflammation, and oxidative stress in a nitroglycerin-induced rat model of migraine

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 37

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-3_013

تاریخ نمایه سازی: 21 اسفند 1404

چکیده مقاله:

Objective(s): Migraine is a debilitating neurological disorder characterized by oxidative stress, neuroinflammation, and dysregulation of the unfolded protein response (UPR) in the brain. Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), has demonstrated neuroprotective properties, but its effects on UPR activation, neuroinflammation, and oxidative stress in migraine are not well defined. This study evaluates the effects of fluoxetine on UPR-related gene expression, inflammatory cytokines, and oxidative stress markers in a nitroglycerin (NTG)-induced chronic migraine rat model.Materials and Methods: Rats were divided into control, NTG-induced chronic migraine, and fluoxetine-treated groups. Behavioral light aversion was assessed. Trigeminal ganglion tissues were analyzed for expression of UPR-associated genes (Bip, XBP-۱, CHOP) and inflammatory markers (IL-۶, IL-۱β, IL-۱۰, NF-κB, TNF-α) using molecular techniques. Serum levels of oxidative stress indicators, including catalase (CAT), superoxide dismutase (SOD), malondialdehyde (MDA), and total antioxidant capacity (TAC), were measured.Results: Our results demonstrate that fluoxetine treatment effectively tempered the maladaptive UPR by modulating the expression of Bip, XBP-۱, and CHOP. It also suppressed neuroinflammation by reducing pro-inflammatory cytokines (TNF-α, IL-۱β, IL-۶) and enhancing the anti-inflammatory cytokine IL-۱۰. Fluoxetine also counteracted oxidative stress by restoring the activity of antioxidant enzymes (SOD, CAT), reducing lipid peroxidation (MDA), and enhancing overall antioxidant capacity (TAC). Importantly, these positive biochemical changes were correlated with a significant reduction in light aversion behavior. Conclusion: Fluoxetine exerts protective effects in an NTG-induced migraine model by modulating UPR pathways, reducing neuroinflammation, and alleviating oxidative stress. These findings highlight its potential as a therapeutic agent targeting multiple pathways in migraine pathophysiology.

نویسندگان

Mahnaz Sadat Moshtaghian

Department of Clinical Biochemistry, Autophagy Research Centre School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Amir Hossein Yousefi Nejad

Department of Physiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Mohammad Reza Namavar

Department of Anatomical Sciences, Histomorphometry and Stereology Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran

Fatemeh Zal

Department of Clinical Biochemistry, Autophagy Research Centre School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Sayed Mohammad Shafiee

Department of Clinical Biochemistry, Autophagy Research Centre School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Zahra Khoshdel

Department of Clinical Biochemistry, Autophagy Research Centre School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Karsan N, Goadsby PJ. Biological insights from the premonitory symptoms ...
  • Agustí A, García-Pardo MP, López-Almela I, Campillo I, Maes M, ...
  • Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the ...
  • Singh VP, Jain NK, Kulkarni SK. On the antinociceptive effect ...
  • Pradhan AA, Smith ML, McGuire B, Tarash I, Evans CJ, ...
  • Zhou T, Zong R, Zhang Z, Zhu C, Pan F, ...
  • Meilhac O, Zhou M, Santanam N, Parthasarathy S. Lipid peroxides ...
  • Minen MT, Begasse De Dhaem O, Kroon Van Diest A, ...
  • Ferroni P, Barbanti P, Della-Morte D, Palmirotta R, Jirillo E, ...
  • Richardson CE, Kinkel S, Kim DH. Physiological IRE-۱-XBP-۱ and PEK-۱ ...
  • Hetz C, Lee AH, Gonzalez-Romero D, Thielen P, Castilla J, ...
  • Bhatti J, Nascimento B, Akhtar U, Rhind SG, Tien H, ...
  • نمایش کامل مراجع